Compounds are provided having agonistic activity against G protein-coupled receptor 35 (GPR35). The compounds are useful for providing antinociception, providing neuroprotection in case of stroke or ischemia, or treating gastric inflammation.
Treatment of Disorders Associated with G protein-Coupled Receptor 35 (GPR35)
Abood, M., Zhao, P., Barak, L., & Seltzman, H. (2015). IPC No. U.S. Treatment of Disorders Associated with G protein-Coupled Receptor 35 (GPR35). (Patent No. 9040583).
Abstract
Publications Info
To contact an RTI author, request a report, or for additional information about publications by our experts, send us your request.